Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | ACP3 | P15309 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | PNMT | P11086 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.43 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | PGK1 | P00558 | 2/20 | 0.42 |
| ▸ | PGK2 | P07205 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8053801 | 0.84 | ACP3 (0.65) | SMN1; SMN2ACP3GRIN2DGRIN3BGRIN1 | |
| SCHEMBL29707862 | 0.84 | ACP3 (0.65) | SMN1; SMN2ACP3GRIN2DGRIN3BGRIN1 | |
| SCHEMBL11772582 | 0.83 | SMN1; SMN2 (0.62) | SMN1; SMN2ACP3IDO1PNMTTAAR1 | |
| SCHEMBL18037951 | 0.80 | CFTR (0.53) | SMN1; SMN2NPC1RAB9AIDO1PNMT | |
| SCHEMBL8958928 | 0.77 | HSD17B10 (0.43) | SMN1; SMN2NPC1RAB9AIDO1PNMT | |
| SCHEMBL8824563 | 0.76 | ACP3 (0.58) | SMN1; SMN2ACP3NPC1RAB9AGRIN2D | |
| SCHEMBL28213109 | 0.76 | ACP3 (0.62) | SMN1; SMN2ACP3GRIN2DGRIN3BGRIN1 | |
| SCHEMBL915357 | 0.76 | ACP3 (0.57) | ACP3IDO1TAAR1GRIN2DGRIN3B | |
| SCHEMBL11499183 | 0.76 | ACP3 (0.57) | SMN1; SMN2ACP3GRIN2DGRIN3BGRIN1 | |
| SCHEMBL11307755 | 0.76 | SMN1; SMN2 (1.00) | SMN1; SMN2ACP3TAAR1LMNAPGK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104744510-B | Alizarin aminophosphonate ester derivatives and synthetic method thereof and application | 广西师范大学 | 2016-08-17 | — | — | CN | claimed |
| CN-102643162-B | A method for preparing 1-(2-chlorophenyl)-2-(4-fluorophenyl) propylene | SINOCHEM CORP | 2014-08-06 | — | — | CN | claimed |
| CN-102643162-A | A method for preparing 1-(2-chlorophenyl)-2-(4-fluorophenyl) propylene | SINOCHEM CORP | 2012-08-22 | — | — | CN | claimed |
| US-20250334727-A1 | OPTICAL FILTER, OPTICAL DEVICE, AND LIGHT-ABSORBING COMPOSITION | NIPPON SHEET GLASS CO LTD (JP) | 2025-10-30 | — | — | US | disclosed |
| US-20250231329-A1 | LIGHT-ABSORBING COMPOSITION, LIGHT-ABSORBING FILM, AND OPTICAL FILTER | NIPPON SHEET GLASS CO LTD (JP) | 2025-07-17 | — | — | US | disclosed |
| US-12313869-B2 | Optical filter, optical device, and light-absorbing composition | NIPPON SHEET GLASS COMPANY, LIMITED (JP) | 2025-05-27 | — | — | US | disclosed |
| US-12287501-B2 | Light-absorbing composition, light-absorbing film, and optical filter | NIPPON SHEET GLASS COMPANY, LIMITED (JP) | 2025-04-29 | — | — | US | disclosed |
| US-12071542-B2 | Light-absorbing composition and optical filter | NIPPON SHEET GLASS COMPANY, LIMITED (JP) | 2024-08-27 | — | — | US | disclosed |
| US-20240192414-A1 | LAMINATE, VISUAL-LINE TRACKING SYSTEM, AND HEAD-MOUNTED DISPLAY | FUJIFILM CORPORATION (JP) | 2024-06-13 | — | — | US | disclosed |
| US-20230400615-A1 | OPTICAL FILTER, OPTICAL DEVICE, AND LIGHT-ABSORBING COMPOSITION | NIPPON SHEET GLASS COMPANY, LIMITED (JP) | 2023-12-14 | — | — | US | disclosed |
| US-11578025-B2 | Processes for the preparation of zuclomiphene intermediates | APOTEX INC. (CA) | 2023-02-14 | — | — | US | disclosed |
| CN-102643162-B | A method for preparing 1-(2-chlorophenyl)-2-(4-fluorophenyl) propylene | SINOCHEM CORP | 2014-08-06 | — | — | CN | disclosed |
| CN-102643162-A | A method for preparing 1-(2-chlorophenyl)-2-(4-fluorophenyl) propylene | SINOCHEM CORP | 2012-08-22 | — | — | CN | disclosed |
| US-5593980-A | ANTIARTHRITIC AGENTS FOR ADMINISTERING | THE UPJOHN COMPANY (US) | 1997-01-14 | — | — | US | disclosed |
| US-5500417-A | ANTIARTHRITIC | THE UPJOHN COMPANY (US) | 1996-03-19 | — | — | US | disclosed |
| EP-0661978-A1 | ARYLMETHYLPHOSPHONATES AND PHOSPHONIC ACIDS USEFUL AS ANTI-INFLAMMATORY AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 1995-07-12 | — | — | EP | disclosed |
| CN-1087092-A | Novel 7 beta-substituted-4-aza-5 alpha-androstan-3-ones as 5 alpha-reductase inhibitors | MERCK & CO INC (US) | 1994-05-25 | — | — | CN | disclosed |
| WO-1994007501-A1 | ARYLMETHYLPHOSPHONATES AND PHOSPHONIC ACIDS USEFUL AS ANTI-INFLAMMATORY AGENTS | THE UPJOHN COMPANY (US) | 1994-04-14 | — | — | WO | disclosed |
| WO-1993023039-A1 | SUBSTITUTED 4-AZA-5A-ANDROSTAN-ONES AS 5A-REDUCTASE INHIBITORS | MERCK & CO., INC. (US) | 1993-11-25 | — | — | WO | disclosed |
| US-4299615-A | PLANT GROWTH REGULATOR | VELSICOL CHEMICAL CORPORATION (US) | 1981-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11578025-B2 | Processes for the preparation of zuclomiphene intermediates | CYP4F2, CYP4F12, CYP1A2 | SMN1; SMN2 4275/4885ACP3 2759/4885NPC1 435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.